Codexis Inc Cash Flow Conversion Efficiency
Codexis Inc cash flow conversion efficiency. Based on the latest financial reports, Codexis Inc (CDXS) has a cash flow conversion efficiency ratio of -0.200x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-7.70 Million) by net assets ($38.54 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Codexis Inc (2006–2024)
Cash flow conversion efficiency of Codexis Inc from 2006 to 2024. This chart illustrates how Codexis Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Codexis Inc share price for real-time trading data and today's change.
Codexis Inc Cash Flow Conversion Ratio Explained
Codexis Inc cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Codexis Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Codexis Inc ranked by their cash flow conversion efficiency. Also see CDXS company net worth for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Orient Technologies Limited
NSE:ORIENTTECH
|
-0.009x |
|
TDG Gold Corp
V:TDG
|
-0.226x |
|
SkyWorld Development Berhad
KLSE:5315
|
-0.182x |
|
Smartphoto Group NV
BR:SMAR
|
0.409x |
|
SOTKAMO SILVER AB NAM.
F:VSO
|
0.214x |
|
My Humble House Hospitality Management Consulting Co Ltd
TW:2739
|
0.458x |
|
Han Chang Pape
KO:009460
|
0.054x |
|
Indústrias Romi S.A
SA:ROMI3
|
-0.005x |
Annual Cash Flow Conversion Efficiency for Codexis Inc (2006–2024)
The table below shows the annual cash flow conversion efficiency of Codexis Inc from 2006 to 2024. Review Codexis Inc free cash flow efficiency to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $66.93 Million | $-49.41 Million | -0.738x | -21.48% |
| 2023-12-31 | $86.61 Million | $-52.64 Million | -0.608x | -879.84% |
| 2022-12-31 | $144.80 Million | $11.28 Million | 0.078x | +189.79% |
| 2021-12-31 | $164.39 Million | $-14.27 Million | -0.087x | +10.33% |
| 2020-12-31 | $170.10 Million | $-16.46 Million | -0.097x | +18.69% |
| 2019-12-31 | $105.52 Million | $-12.56 Million | -0.119x | +52.45% |
| 2018-12-31 | $56.31 Million | $-14.09 Million | -0.250x | +29.88% |
| 2017-12-31 | $24.55 Million | $-8.76 Million | -0.357x | -152.43% |
| 2016-12-31 | $19.10 Million | $-2.70 Million | -0.141x | -647.25% |
| 2015-12-31 | $22.88 Million | $-433.00K | -0.019x | -255.13% |
| 2014-12-31 | $26.31 Million | $321.00K | 0.012x | +102.20% |
| 2013-12-31 | $41.48 Million | $-23.00 Million | -0.554x | -265.68% |
| 2012-12-31 | $78.44 Million | $-11.89 Million | -0.152x | -3077.24% |
| 2011-12-31 | $102.69 Million | $-490.00K | -0.005x | +96.87% |
| 2010-12-31 | $107.36 Million | $-16.38 Million | -0.153x | +35.29% |
| 2009-12-31 | $36.84 Million | $-8.69 Million | -0.236x | -183.84% |
| 2008-12-31 | $-129.12 Million | $-36.32 Million | 0.281x | +280.22% |
| 2007-12-31 | $-87.47 Million | $-6.47 Million | 0.074x | -70.62% |
| 2006-12-31 | $-52.77 Million | $-13.29 Million | 0.252x | -- |
About Codexis Inc
Codexis, Inc. provides enzymatic solutions for therapeutics manufacturing, leveraging its proprietary CodeEvolver technology platform to discover, develop, and enhance novel enzymes in the United States, Canada, Latin America, Europe, the Middle East, Africa, Australia, New Zealand, Southeast Asia, and China. The company develops its proprietary ECO Synthesis manufacturing platform to enable the … Read more